Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT02954705
Eligibility Criteria:
Inclusion Criteria for patients:
* Adult patients aged over 18 years
* Patients with Granulomatosis with polyangiitis or microscopic polyangiitis meeting the criteria of Chapel Hill.
* corticosteroid treatment \<20 mg / day.
* Informed consent: oral for participation in research and writing for biological collection.
Inclusion Criteria for controls patients:
\- healthy-topics matched for age, recruited from the Etablissement français du sang or in the Department of Internal Medicine of Nantes University Hospital
Non Inclusion Criteria:
* ANCA-associated vasculitis with Eosinophilic granulomatosis with polyangiitis (AAV-EGPA).
* Infectious or progressive tumor pathology.
* Pregnancy, lactation
* Treatment with cyclophosphamide in the 6 months prior to inclusion.
* Terminal chronic renal failure, presence of organ allograft.
* Thrust Patients receiving corticosteroids\> 20 mg / d in the previous 4 weeks.
* Inability to give informed about information (subject in emergencies, understanding of the subject of difficulty, ...)
* Minor subject, under judicial protection, guardianship
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02954705
Study Brief:
Protocol Section:
NCT02954705